S. Falcon

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial

Jaffer A. Ajani, W. Rodriguez, G. Bodoky et al. · Journal of Clinical Oncology · 2010 · 565 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2014 · 431 citations · Full text

Medicine, Oncology, Pharmacology +15

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial

Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor et al. · Journal of Clinical Oncology · 2009 · 341 citations · Full text

Medicine, Oncology, Pharmacology +13

HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up

Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy et al. · European Journal of Cancer · 2016 · 78 citations · Full text

Medicine, Oncology, Pharmacology +12

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2013 · 70 citations

Medicine, Oncology, Pharmacology +16